MEK is a promising target in the basal subtype of bladder cancer

Abstract

While many resources exist for the drug screening of bladder cancer cell lines in 2D culture, it is widely recognized that screening in 3D culture is more representative of in vivo response. Importantly, signaling changes between 2D and 3D culture can result in changes to drug response. To address the need for 3D drug screening of bladder cancer cell lines, we screened 17 bladder cancer cell lines using a library of 652 investigational small-molecules and 3 clinically relevant drug combinations in 3D cell culture. Our goal was to identify compounds and classes of compounds with efficacy in bladder cancer. Utilizing established genomic and transcriptomic data for these bladder cancer cell lines, we correlated the genomic molecular parameters with drug response, to identify potentially novel groups of tumors that are vulnerable to specific drugs or classes of drugs. Importantly, we demonstrate that MEK inhibitors are a promising targeted therapy for the basal subtype of bladder cancer, and our data indicate that drug screening of 3D cultures provides an important resource for hypothesis generation.

Optimizing Precision Medicine for Breast Cancer Brain Metastases with Functional Drug Response Assessment

“…Cells were screened in 384-well ultra-low attachment plates (Corning, 4516 or S-Bio, MS-9384WZ) in singlicate or duplicate, 7-point dose–response format. Cells were plated in our previously defined SM+6 medium ( 30 ). Cells were plated on day 0 at 3,000 cells per well.…”

Bortezomib advanced mechanisms of action in multiple myeloma, solid and liquid tumors along with its novel therapeutic applications

“…Recently, an underlying enzyme named as Ubiquitin C-terminal hydrolase L5 (UCHL5) was suggested to be a contributing factor for tumor growth progression and metastasis occurrence in multiple cancer tumors as endometrial cancer (EC). To identify the role of UCHL5 on EC, bioinformatics analysis revealed that UCHL5 overexpression in EC tissues lead to lower overall survival (Merrill et al, 2020[ 105 ]). Hence, UCHL5 was seen to be reversibly associated with the 26S proteasome in order to prevent target proteins degradation by hydrolyzing ubiquitin chains (Rastogi and Mishra, 2012[ 126 ]).…”